ALPS Advisors’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $710K | Buy |
+47,948
| New | +$710K | ﹤0.01% | 581 |
|
|
2024
Q2 | – | Sell |
-53,672
| Closed | -$414K | – | 1003 |
|
|
2024
Q1 | $414K | Buy |
53,672
+6,617
| +14% | +$51K | ﹤0.01% | 618 |
|
|
2023
Q4 | $423K | Sell |
47,055
-8,319
| -15% | -$74.8K | ﹤0.01% | 637 |
|
|
2023
Q3 | $495K | Buy |
55,374
+531
| +1% | +$4.75K | ﹤0.01% | 599 |
|
|
2023
Q2 | $842K | Buy |
54,843
+6,731
| +14% | +$103K | 0.01% | 525 |
|
|
2023
Q1 | $1.08M | Buy |
48,112
+4,612
| +11% | +$104K | 0.01% | 455 |
|
|
2022
Q4 | $915K | Buy |
43,500
+8,587
| +25% | +$181K | 0.01% | 501 |
|
|
2022
Q3 | $860K | Sell |
34,913
-2,766
| -7% | -$68.1K | 0.01% | 496 |
|
|
2022
Q2 | $913K | Sell |
37,679
-27,576
| -42% | -$668K | 0.01% | 496 |
|
|
2022
Q1 | $1.68M | Sell |
65,255
-5,599
| -8% | -$144K | 0.02% | 258 |
|
|
2021
Q4 | $2.2M | Sell |
70,854
-3,557
| -5% | -$110K | 0.02% | 281 |
|
|
2021
Q3 | $1.8M | Sell |
74,411
-5,214
| -7% | -$126K | 0.02% | 331 |
|
|
2021
Q2 | $1.16M | Sell |
79,625
-29,350
| -27% | -$428K | 0.01% | 388 |
|
|
2021
Q1 | $2.72M | Buy |
108,975
+16,963
| +18% | +$424K | 0.03% | 228 |
|
|
2020
Q4 | $2.51M | Buy |
+92,012
| New | +$2.51M | 0.03% | 243 |
|